A Clinical Evaluation Report (CER) is one of the most critical and heavily scrutinized regulatory documents in the medical device lifecycle. It provides documented evidence that a medical device is clinically safe, performs as intended, and delivers a favorable benefit-risk profile for patients and users.
With the introduction of the EU Medical Device Regulation (EU MDR 2017/745), the role of the Clinical Evaluation Report has evolved dramatically. CERs are no longer static, submission-only documents. Instead, they are now living clinical evidence files that must be actively maintained and updated throughout the entire product lifecycle.
For manufacturers, notified bodies, and regulatory authorities, a robust CER is essential to:
- Obtain and maintain CE marking
- Demonstrate compliance with General Safety and Performance Requirements (GSPRs)
- Support post-market surveillance (PMS) and PMCF
- Withstand increasing regulatory scrutiny and audits
- Protect patient safety and clinical outcomes
This comprehensive guide explains the definition, regulatory foundation, structure, best practices, and emerging trends shaping Clinical Evaluation Reports today.
What Is a Clinical Evaluation Report?
A Clinical Evaluation Report is a formal, systematic, and documented assessment of clinical data related to a medical device. Its primary objective is to confirm that the device:
- Achieves its intended purpose
- It is safe for patients and users
- Performs consistently under normal conditions of use
- Demonstrates a positive benefit-to-risk ratio
- Aligns with the current state of the art (SOTA)
Clinical data included in a CER may come from:
- Pre-market and post-market clinical investigations
- Published scientific and clinical literature
- Post-market surveillance data
- Post-Market Clinical Follow-Up (PMCF)
- Real-world evidence (RWE)
Under EU MDR, clinical evaluation is a continuous process, not a one-time activity.
Regulatory Importance of the Clinical Evaluation Report
Why CERs Are Heavily Scrutinized
Notified bodies consistently identify CER-related non-conformities as one of the leading causes of:
- Certification delays
- Additional clinical evidence requests
- Suspended or withdrawn CE certificates
Common regulatory concerns include:
- Insufficient clinical data for the intended use
- Weak literature appraisal methodology
- Unsupported equivalence claims
- Poor linkage between CER, PMS, and risk management
- Outdated or incomplete clinical conclusions
A well-prepared Clinical Evaluation Report directly reduces regulatory risk and accelerates market access.
Regulatory Framework Governing Clinical Evaluation Reports
EU MDR 2017/745 Requirements
Clinical evaluation requirements are primarily defined in:
- Article 61 – Clinical Evaluation
- Annex I – General Safety and Performance Requirements
- Annex XIV – Clinical Evaluation and PMCF
Key MDR expectations include:
- Use of qualified clinical evaluators
- Methodologically sound literature searches
- Objective appraisal and analysis of clinical data
- Justification of clinical claims
- Regular CER updates using PMS and PMCF data
Although MEDDEV 2.7/1 Rev. 4 is no longer legally binding, it remains widely used as a best-practice guidance document.
Clinical Evaluation Report Lifecycle Approach
Modern CERs follow a lifecycle-based approach, meaning they must be:
- Created during device development
- Updated after certification
- Reviewed periodically
- Revised when new clinical, PMS, or PMCF data becomes available
Any of the following can trigger a CER update:
- Design changes
- Expanded indications
- New clinical risks
- Serious incidents or trends
- Regulatory feedback
Standard Structure of a Clinical Evaluation Report
1. Executive Summary
A concise overview of:
- Device description
- Intended purpose
- Clinical evidence sources
- Overall clinical conclusions
2. Device Description and Intended Purpose
Includes:
- Device classification
- Intended use, indications, and contraindications
- Target patient population
- Principle of operation
- Accessories and variants
Clear alignment between intended purpose and clinical evidence is critical.
3. Scope of Clinical Evaluation
Defines:
- Regulatory pathway
- Clinical claims to be supported
- Applicable standards and guidance
- Evaluation objectives and limitations
4. Identification of Clinical Data
Documents:
- Literature search strategy
- Databases used (PubMed, Embase, Cochrane, etc.)
- Search terms and timeframes
- Inclusion and exclusion criteria
Transparency in search methodology is a key audit focus.
5. Appraisal of Clinical Data
Evaluates:
- Scientific validity
- Methodological quality
- Bias and limitations
- Relevance to the device and intended use
Poor appraisal methodology is one of the most common CER deficiencies.
6. Analysis of Clinical Data
Analyzes:
- Safety outcomes and adverse events
- Clinical performance endpoints
- Comparison to SOTA
- Consistency across data sources
7. Benefit-Risk Assessment
Demonstrates:
- Identified clinical benefits
- Known and foreseeable risks
- Risk mitigation measures
- Overall benefit-risk justification
8. Clinical Conclusions
Confirms whether:
- Clinical evidence is sufficient
- GSPRs are met
- PMCF is required or justified
Claims are clinically supported
State of the Art (SOTA) in Clinical Evaluation Reports
Defining State of the Art is a mandatory MDR requirement. SOTA represents:
- Current clinical practices
- Existing alternative therapies or devices
- Accepted safety and performance benchmarks
The CER must show that the device:
- Performs at least as well as available alternatives
- Does not introduce unacceptable new risks
- Remains clinically relevant over time
Equivalence in Clinical Evaluation Reports
Challenges Under EU MDR
Equivalence claims must be justified across:
- Clinical equivalence
- Technical equivalence
- Biological equivalence
Manufacturers must have:
- Sufficient access to technical documentation
- Strong scientific justification
- Clear rationale for relevance
Due to stricter MDR expectations, reliance on equivalence alone has become increasingly difficult.
Role of PMCF in Clinical Evaluation Reports
Post-Market Clinical Follow-Up
PMCF is an essential component of ongoing clinical evaluation. Under MDR:
- PMCF is expected for most devices
- Justification is required if PMCF is not conducted
- PMCF outputs must feed directly into CER updates
PMCF activities may include:
- Post-market clinical studies
- Registries
- Surveys and feedback
- Real-world performance analysis
Trending Topic: CERs for Software and AI Medical Devices
For Software as a Medical Device (SaMD) and AI-based devices, CERs must address:
- Clinical validation of algorithms
- Dataset relevance and representativeness
- Bias and performance drift
- Usability and cybersecurity risks
Regulators increasingly expect real-world performance monitoring for adaptive AI systems.
Trending Topic: Real-World Evidence (RWE) in CERs
Real-world evidence is gaining acceptance when:
- Clinical trials are impractical
- Long-term safety data is needed
- PMCF supports ongoing performance claims
RWE must still meet standards for data quality, relevance, and traceability.
Common CER Deficiencies Identified by Notified Bodies
Frequent findings include:
- Incomplete literature searches
- Unsupported clinical claims
- Weak benefit-risk analysis
- Missing linkage to risk management
- Infrequent CER updates
Proactively addressing these issues significantly improves approval success.
Best Practices for High-Quality Clinical Evaluation Reports
From real regulatory experience:
- Start clinical evaluation early
- Use qualified clinical experts
- Maintain traceability to GSPRs
- Align CER, PMS, PMCF, and risk files
- Treat the CER as a strategic document, not an administrative task
Conclusion
The Clinical Evaluation Report is a cornerstone of medical device regulatory compliance. In the EU MDR era, CERs must be robust, transparent, continuously updated, and scientifically sound.
Manufacturers that invest in high-quality clinical evaluation not only achieve regulatory approval faster but also strengthen patient trust, clinical credibility, and long-term market success.
